$NAYA
Stock $naya

$naya Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040488 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$1.382M	$974.9K	$278.1K
YoY Change	396.78%	314.28%	-90.88%
Cost Of Revenue	$886.8K	$580.0K	$79.19K
YoY Change	1019.78%	431.54%	67.46%
Gross Profit	$495.0K	$390.0K	$199.0K
YoY Change	148.81%	209.02%	-93.37%
Gross Profit Margin	35.82%	40.0%	71.53%
Selling, General & Admin	$1.856M	$1.257M	$2.843M
YoY Change	-34.73%	-49.24%	16.84%
% of Gross Profit	374.94%	322.32%	1429.21%
Research & Development	$5.910K	$2.668K	$73.84K
YoY Change	-92.0%	-98.48%	15.81%
% of Gross Profit	1.19%	0.68%	37.11%
Depreciation & Amortization	$140.9K	$20.50K	$19.94K
YoY Change	606.57%	77.89%	388.73%
% of Gross Profit	28.46%	5.26%	10.02%
Operating Expenses	$2.003M	$1.861M	$2.917M
YoY Change	-31.32%	-29.81%	16.81%
Operating Profit	-$1.508M	-$886.3K	-$2.718M
YoY Change	-44.51%	-64.91%	-639.82%
Interest Expense	-$210.2K	$352.1K	-$46.66K
YoY Change	350.49%	19893.47%	-88.39%
% of Operating Profit
Other Income/Expense, Net		-$360.3K
YoY Change		1388.39%
Pretax Income	-$1.972M	-$1.247M	-$2.765M
YoY Change	-28.69%	-51.11%	-2816.6%
Income Tax	$23.04K	$1.886K	$2.070K
% Of Pretax Income
Net Earnings	-$1.995M	-$1.248M	-$2.767M
YoY Change	-27.91%	-51.03%	1855.09%
Net Earnings / Revenue	-144.37%	-128.06%	-994.84%
Basic Earnings Per Share		-$0.70
Diluted Earnings Per Share	-$1.27	-$0.70	-$0.23
COMMON SHARES
Basic Shares Outstanding	2.475M shares	2.450M shares	12.17M shares
Diluted Shares Outstanding		1.777M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$232.4K	$1.060M	$90.14K
YoY Change	157.84%	271.02%	-98.41%
Cash & Equivalents	$232.4K	$1.056M	$90.14K
Short-Term Investments
Other Short-Term Assets	$622.3K	$370.0K	$190.2K
YoY Change	227.18%	21.25%	-32.73%
Inventory	$264.5K	$254.2K	$263.6K
Prepaid Expenses
Receivables	$140.6K	$116.8K	$77.15K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.260M	$1.792M	$621.1K
YoY Change	102.83%	90.15%	-90.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.567M	$772.4K	$436.7K
YoY Change	1403.76%	69.27%	-12.9%
Goodwill	$5.879M	$8.225M
YoY Change
Intangibles	$4.093M	$1.750M	$0.00
YoY Change		1218.97%	-100.0%
Long-Term Investments	$3.088M	$1.080M	$1.238M
YoY Change	149.48%	-15.71%	-16.92%
Other Assets
YoY Change
Total Long-Term Assets	$19.63M	$17.68M	$3.483M
YoY Change	463.6%	373.35%	-16.29%
TOTAL ASSETS
Total Short-Term Assets	$1.260M	$1.792M	$621.1K
Total Long-Term Assets	$19.63M	$17.68M	$3.483M
Total Assets	$20.89M	$19.48M	$4.104M
YoY Change	409.0%	316.31%	-60.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.330M	$1.850M	$1.349M
YoY Change	72.74%	168.29%	204.24%
Accrued Expenses	$1.120M	$980.0K	$1.178M
YoY Change	-4.93%	12.28%	46.56%
Deferred Revenue
YoY Change
Short-Term Debt	$880.0K	$880.0K	$662.6K
YoY Change	32.8%
Long-Term Debt Due	$629.9K	$820.0K	$100.0K
YoY Change	529.92%
Total Short-Term Liabilities	$8.219M	$4.884M	$3.409M
YoY Change	141.06%	194.05%	172.1%
LONG-TERM LIABILITIES
Long-Term Debt	$1.254M	$1.100M	$0.00
YoY Change
Other Long-Term Liabilities	$10.52M	$13.12M	$1.670M
YoY Change	530.08%	658.86%	-12.18%
Total Long-Term Liabilities	$11.78M	$14.22M	$1.670M
YoY Change	605.18%	722.48%	-12.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.219M	$4.884M	$3.409M
Total Long-Term Liabilities	$11.78M	$14.22M	$1.670M
Total Liabilities	$19.99M	$19.10M	$5.081M
YoY Change	293.5%	463.35%	61.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.80M	-$55.80M	-$49.80M
YoY Change	16.06%	18.72%	28.05%
Common Stock	$52.71M	$56.20M	$48.81M
YoY Change	8.0%	16.34%	4090924.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$892.8K	$372.8K	-$977.6K
YoY Change
Total Liabilities & Shareholders Equity	$20.89M	$19.48M	$4.104M
YoY Change	409.0%	316.31%	-60.79%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.995M	-$1.248M	-$2.767M
YoY Change	-27.91%	-51.03%	1855.09%
Depreciation, Depletion And Amortization	$140.9K	$20.50K	$19.94K
YoY Change	606.57%	77.89%	388.73%
Cash From Operating Activities	-$715.0K	-$1.250M	-$1.004M
YoY Change	-28.79%	-24.16%	-33.55%
INVESTING ACTIVITIES
Capital Expenditures	$74.72K	$110.0K	-$130.00
YoY Change	-57576.92%	-3766.67%	-100.04%
Acquisitions
YoY Change
Other Investing Activities	$109.8K	-$2.150M	$8.450K
YoY Change	1199.88%		-100.68%
Cash From Investing Activities	$35.12K	-$2.260M	$8.580K
YoY Change	309.32%	74983.06%	-100.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-137.8K	4.440M	800.0K
YoY Change	-117.22%	-17719.05%	-76.48%
NET CHANGE
Cash From Operating Activities	-715.0K	-1.250M	-1.004M
Cash From Investing Activities	35.12K	-2.260M	8.580K
Cash From Financing Activities	-137.8K	4.440M	800.0K
Net Change In Cash	-817.7K	930.0K	-195.6K
YoY Change	318.12%	-155.47%	-120.13%
FREE CASH FLOW
Cash From Operating Activities	-$715.0K	-$1.250M	-$1.004M
Capital Expenditures	$74.72K	$110.0K	-$130.00
Free Cash Flow	-$789.8K	-$1.360M	-$1.004M
YoY Change	-21.34%	-17.34%	-45.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001417926
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent		usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	INVO	Stock Issued During Period Value Warrant Exercised StockIssuedDuringPeriodValueWarrantExercised		usd
CY2023Q3	INVO	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	INVO	Stock Issued During Period Value Warrant Exercised StockIssuedDuringPeriodValueWarrantExercised		usd
	INVO	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	INVO	Proceeds From Option Exercises ProceedsFromOptionExercises		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	INVO	Fair Value Of Warrants Issued With Debt FairValueOfWarrantsIssuedWithDebt		usd
	INVO	Fair Value Of Shares Issued For Settlement Of Liability FairValueOfSharesIssuedForSettlementOfLiability		usd
	INVO	Initial Rou Asset And Lease Liability InitialRouAssetAndLeaseLiability		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	INVO	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q4	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsOutstanding		usd
	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsGranted		usd
	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsExercised		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	INVO	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsForfeiture		usd
CY2023Q3	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsOutstanding		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39701
	dei	Entity Registrant Name EntityRegistrantName	INVO Bioscience, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4036208
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5582 Broadcast Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sarasota
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34240
	dei	City Area Code CityAreaCode	(978)
	dei	Local Phone Number LocalPhoneNumber	878-9505
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	INVO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2474756	shares
CY2023Q3	us-gaap	Cash Cash	1055544	usd
CY2022Q4	us-gaap	Cash Cash	90135	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	116781	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77149	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	254220	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	263602	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	365227	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	190201	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1791772	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	621087	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	772447	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	436729	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5858042	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1808034	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1750000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	8224708	usd
CY2023Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1079202	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1237865	usd
CY2023Q3	us-gaap	Assets Assets	19476171	usd
CY2022Q4	us-gaap	Assets Assets	4103715	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1851783	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1349038	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590598	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	946262	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	229921	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	119876	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	385836	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	231604	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	123432	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4884144	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3409424	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1095000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5622279	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1669954	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1949	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1949	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7500000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	19103372	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5081327	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2474756	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2474756	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	608611	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	608611	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	247	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	61	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56195915	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	48805860	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55823363	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49783533	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	372799	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-977612	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19476171	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4103715	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	974894	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	235321	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1638821	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	544054	usd
CY2023Q3	INVO	Costs Of Revenue CostsOfRevenue	580968	usd
CY2022Q3	INVO	Costs Of Revenue CostsOfRevenue	248977	usd
	INVO	Costs Of Revenue CostsOfRevenue	1047687	usd
	INVO	Costs Of Revenue CostsOfRevenue	616184	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1257044	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2316763	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5630487	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7308478	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2668	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	175267	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	160038	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	470208	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20504	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19732	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59296	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	57361	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1861184	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2760739	usd
	us-gaap	Operating Expenses OperatingExpenses	6897508	usd
	us-gaap	Operating Expenses OperatingExpenses	8452231	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-886290	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2525418	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5258687	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7908177	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8163	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-21470	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-32110	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-210565	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	34	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	307	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	352085	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1761	usd
	us-gaap	Interest Expense InterestExpense	743866	usd
	us-gaap	Interest Expense InterestExpense	3319	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-16	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1008	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-416	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2922	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-360264	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24205	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-776392	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-216499	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1246554	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2549623	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6035079	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8124676	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1886	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4751	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1248440	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2549623	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6039830	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8125476	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.42
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.42
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1776898	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	607783	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1048115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	605356	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1776898	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	607783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1048115	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605356	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3356425	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	79479	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-25200	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	426143	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2549623	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1287224	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1705494	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1705494	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2670	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11249	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2996061	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	65198	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	251555	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1248440	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	372799	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	372799	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7310680	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	408027	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	116766	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	289800	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1287427	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8125476	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1287224	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-977612	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	54235	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	255424	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5725000	usd
	INVO	Stock Issued During Period Value Common Stock Issued With Notes Payable StockIssuedDuringPeriodValueCommonStockIssuedWithNotesPayable	56314	usd
	INVO	Stock Issued During Period Value Common Stock Issued For Liability Settlement StockIssuedDuringPeriodValueCommonStockIssuedForLiabilitySettlement	65198	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2375	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	904305	usd
	INVO	Adjustments To Additional Paid In Capital Warrants Issued With Notes Payable AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedWithNotesPayable	327390	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6039830	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	372799	usd
	us-gaap	Profit Loss ProfitLoss	-6039830	usd
	us-gaap	Profit Loss ProfitLoss	-8125476	usd
	INVO	Noncash Stock Compensation Issued For Services NoncashStockCompensationIssuedForServices	255424	usd
	INVO	Noncash Stock Compensation Issued For Services NoncashStockCompensationIssuedForServices	116766	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	54235	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	408027	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	904305	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1287427	usd
	INVO	Noncash Compensation For Services NoncashCompensationForServices	135000	usd
	INVO	Noncash Compensation For Services NoncashCompensationForServices	75000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	612259	usd
	INVO	Loss From Equity Method Investments LossFromEquityMethodInvestments	32110	usd
	INVO	Loss From Equity Method Investments LossFromEquityMethodInvestments	210565	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59296	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	57361	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39632	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20841	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-9382	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-7642	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	175026	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	22400	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	567944	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	246136	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-355664	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	61919	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	110045	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	92759	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-226568	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	56549	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	5941	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4040171	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5599174	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	369722	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10920	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1943	usd
	INVO	Investment In Joint Ventures InvestmentInJointVentures	8447	usd
	INVO	Investment In Joint Ventures InvestmentInJointVentures	76937	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2150000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2528169	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89800	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3060250	usd
	INVO	Proceeds From Sale Of Notes Payable Related Parties ProceedsFromSaleOfNotesPayableRelatedParties	100000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5725000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	289800	usd
	INVO	Proceeds From Option Exercises ProceedsFromOptionExercises	2375	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1353876	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7533749	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	289800	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	965409	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5399174	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90135	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5684871	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1055544	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	285697	usd
	us-gaap	Interest Paid Net InterestPaidNet	9640	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	INVO	Fair Value Of Warrants Issued With Debt FairValueOfWarrantsIssuedWithDebt	383704	usd
	INVO	Fair Value Of Shares Issued For Settlement Of Liability FairValueOfSharesIssuedForSettlementOfLiability	65198	usd
	INVO	Initial Rou Asset And Lease Liability InitialRouAssetAndLeaseLiability	4269881	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zCWKZG0l2vAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zVBnk1kkjuFi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-6039830	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8125476	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1776898	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1776898	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	607783	shares
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	607783	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1048115	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1048115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	605356	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	605356	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z9KxjTNtUata" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zODdVObLdxuk">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Corporation (“FDIC”) limits. As of September 30, 2023, the Company had cash balances in excess of FDIC limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1248440	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2549623	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1776898	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	607783	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1048115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	605356	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.19
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.42
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.19
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.42
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3646665	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86988	shares
	us-gaap	Net Income Loss NetIncomeLoss	-6000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8100000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55800000	usd
	INVO	Net Income Loss Related To Non Cash Expenses NetIncomeLossRelatedToNonCashExpenses	2100000	usd
	INVO	Net Income Loss Related To Non Cash Expenses NetIncomeLossRelatedToNonCashExpenses	2300000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5800000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	3200000	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1492520	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1533957	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4846417	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4793450	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-998380	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2057245	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5128430	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-9571686	usd
CY2021Q2	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	1.50	pure
	INVO	Investment In Unconsolidated Variable Interest Entities InvestmentInUnconsolidatedVariableInterestEntities	1079202	usd
CY2022	INVO	Investment In Unconsolidated Variable Interest Entities InvestmentInUnconsolidatedVariableInterestEntities	1237865	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	68723	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	191780	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	194879	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	254220	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	263602	usd
CY2023Q3	INVO	Earning From Unconsolidated Variable Interest Entities EarningFromUnconsolidatedVariableInterestEntities	-8163	usd
CY2022Q3	INVO	Earning From Unconsolidated Variable Interest Entities EarningFromUnconsolidatedVariableInterestEntities	-21470	usd
	INVO	Earning From Unconsolidated Variable Interest Entities EarningFromUnconsolidatedVariableInterestEntities	-32110	usd
	INVO	Earning From Unconsolidated Variable Interest Entities EarningFromUnconsolidatedVariableInterestEntities	-210565	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	62440	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	212563	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	153267	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	772447	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	436729	usd
CY2023Q3	us-gaap	Depreciation Depreciation	20504	usd
CY2022Q3	us-gaap	Depreciation Depreciation	19279	usd
	us-gaap	Depreciation Depreciation	59296	usd
	us-gaap	Depreciation Depreciation	56004	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	453	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1357	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5858042	usd
CY2023Q3	INVO	Right Of Use Assets RightOfUseAssets	5858042	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	385836	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5622279	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6008115	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	144953	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	616158	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	622676	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	638469	usd
CY2023Q3	INVO	Lessee Operating Lease Liability Payments Due After Year Three LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree	5943918	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7966174	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1958059	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6008115	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	372800	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	107356	usd
CY2023Q3	INVO	Financing Fee Related Party Demand Notes Percentage FinancingFeeRelatedPartyDemandNotesPercentage	0.10	pure
CY2023Q3	INVO	Annual Interest Related Party Demand Notes Percentage AnnualInterestRelatedPartyDemandNotesPercentage	0.10	pure
CY2023Q3	INVO	Annual Interest Related Party Demand Notes Percentage AnnualInterestRelatedPartyDemandNotesPercentage	0.10	pure
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	372800	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	107356	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	2797574	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	762644	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	17500	shares
CY2022Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200000	usd
CY2022Q4	us-gaap	Debt Instrument Description DebtInstrumentDescription	These notes accrue 10% annual interest accrues from the date of issuance. These notes are callable with 10 days prior written notice. At maturity, the Company agreed to pay outstanding principal, a 10% financing fee and accrued interest.
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	410000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	410000	usd
CY2022Q4	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	310000	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	12.00
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	19375	shares
CY2023Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-12-31
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2023Q1	us-gaap	Share Price SharePrice	10.40
CY2023Q1	us-gaap	Share Price SharePrice	10.40
CY2023Q1	INVO	Percentage Of Debentures Outstanding PercentageOfDebenturesOutstanding	0.50	pure
CY2023Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	(i) in a minimum amount of not less than $25,000 and (ii) in a maximum amount of up to the lesser of (a) $750,000 or (b) 200% of the Company’s average daily trading value of the Common Stock.
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2375	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	64850	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	59048	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.74
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	297	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10973	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	70.68
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	112628	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.90
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	82661	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	58.23
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.036	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0369	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.016	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.066	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.149	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.104	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.132	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1616401	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	896257	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	25884	shares
CY2022Q4	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceWarrants	30.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3643526	shares
	INVO	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	3.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	180790	shares
	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Of Warrants Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOfWarrantsExercised	1.16
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3488620	shares
CY2023Q3	INVO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceWarrants	3.95
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1886	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4751	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure

Files In Submission

Name	View Source	Status
0001493152-23-040488-index-headers.html	Edgar Link	pending
0001493152-23-040488-index.html	Edgar Link	pending
0001493152-23-040488.txt	Edgar Link	pending
0001493152-23-040488-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form-10q.htm	Edgar Link	pending
invo-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
invo-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
invo-20230930_def.xml	Edgar Link	unprocessable
invo-20230930_lab.xml	Edgar Link	unprocessable
invo-20230930_pre.xml	Edgar Link	unprocessable
form-10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NAYA
Stock $naya

2023 Q4 Form 10-Q Financial Statement

#000149315223040488 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NAYA Stock $naya

2023 Q4 Form 10-Q Financial Statement

#000149315223040488 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NAYA
Stock $naya